UTHR - United Therapeutics Q2 2022 Earnings Preview

• United Therapeutics ( NASDAQ: UTHR ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open.
• The consensus EPS Estimate is $4.54 (+11.0% Y/Y) and the consensus Revenue Estimate is $461.06M (+3.3% Y/Y).
• Over the last 2 years, UTHR has beaten EPS estimates 75% of the time and has beaten revenue estimates 88% of the time.
• Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 5 upward revisions and 5 downward.

For further details see: